Skip Navigation

Loyola University Medical Center

Location

Loyola University Medical Center
Bone Marrow Transplant Program
Building 112, Room D29
2160 South First Avenue
Maywood, IL 60153
Direct phone: (708) 327-3216

Total transplants by cell source

From January 1, 2019 to December 31st, 2020
  • Marrow: 30
  • PBSC: 51
  • Cord Blood: 21
  • Autologous (PBSC or Marrow): 122
Performs adult transplants

Overview

Formed in 1996, LUMC is a FACT-accredited transplant program affiliated with the SWOG clinical trials. We provide a multidisciplinary team approach to related, unrelated and auto transplants for adults with a variety of hematologic/solid tumor diseases. We offer CAR T cellular therapy using an FDA approved product and an in-house clinical trial.

This center has been performing allogeneic transplants since 1986 and has been an NMDP/Be The Match transplant center since December 1996.

Attending physicians

Adult - Patrick Hagen, Charles Hemenway, Nasheed Hossain, Scott Smith, Patrick J. Stiff, Stephanie Tsai

Pediatric - Charles Hemenway

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

Our Bone Marrow Transplant and Cellular Therapy Program is a comprehensive adult program that is FACT accredited for both autologous and allogeneic transplants. We have discounted housing available within a few miles of campus through our nearby hotels. Our patients receive personalized care throughout the BMT process with a dedicated team of BMT physicians, Advanced Practice Providers (APPs) and a specifically assigned Transplant Nurse Coordinators. Our care team also includes BMT-specific RNs, Social Workers, Nutritionists, Clinical Pharmacist, Psychologists, and Physical Therapists.

About the center

Overview

Formed in 1996, LUMC is a FACT-accredited transplant program affiliated with the SWOG clinical trials. We provide a multidisciplinary team approach to related, unrelated and auto transplants for adults with a variety of hematologic/solid tumor diseases. We offer CAR T cellular therapy using an FDA approved product and an in-house clinical trial.

This center has been performing allogeneic transplants since 1986 and has been an NMDP/Be The Match transplant center since December 1996.

Attending physicians

Adult - Patrick Hagen, Charles Hemenway, Nasheed Hossain, Scott Smith, Patrick J. Stiff, Stephanie Tsai

Pediatric - Charles Hemenway

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

Our Bone Marrow Transplant and Cellular Therapy Program is a comprehensive adult program that is FACT accredited for both autologous and allogeneic transplants. We have discounted housing available within a few miles of campus through our nearby hotels. Our patients receive personalized care throughout the BMT process with a dedicated team of BMT physicians, Advanced Practice Providers (APPs) and a specifically assigned Transplant Nurse Coordinators. Our care team also includes BMT-specific RNs, Social Workers, Nutritionists, Clinical Pharmacist, Psychologists, and Physical Therapists.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are below the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 130 patients.

The actual 1-year survival of these patients is 63.5%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 64.9% and 79.4%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


224

Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 2 29 0 31
Unrelated donor 28 22 21 71
Total allogeneic 30 51 21 102
Autologous
Both marrow & PBSC
122
-- 122
Total combined
203 21 224

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 1 7 15 8 31
Unrelated 0 14 31 26 71
Autologous 2 11 55 54 122
Total 3 32 101 88 224

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Sheila Wojtowicz
(708) 327-3210
Email: swojtow@lumc.edu

Financial representative:
Pamela Terrazino
(708) 216-4803
Email: pterraz@lumc.edu

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

Loading survivorship program information...